Today, doctors are increasingly looking at the genetic makeup of each patient’s tumor to guide treatment decisions.

A new study found that at least 70 genetic mutations are involved in the formation of colon cancer, significantly more than was previously thought, according to a news release by UT Southwestern ...

Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene - a gene that can cause cancer - that may play an important role in colon cancer. Researchers also showed how this ...

Taking aspirin on a daily basis protects against the recurrence of colon cancer, a new study found. People who took aspirin every day for three years had a 55% reduced risk of colorectal cancer tumors ...

In a new study, low-dose daily aspirin roughly halved the risk of cancer coming back for patients whose tumors had a specific genetic mutation. Daily low-dose aspirin halves the risk of colorectal ...

FDA has announced it has approved the first genetic test that can help some colorectal cancer patients and their doctors determine if the drug Erbitux (cetuximab) would be an effective treatment based ...

It impacts roughly 1 in 300 Americans — and puts people at a higher risk of developing cancer before age 50.

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...

First, the good news. Among Americans under 50, the overall cancer mortality has plummeted by 44% over the last ...